Clinical Trials Directory

Trials / Completed

CompletedNCT02099032

Milk Polar Lipids Consumption, Lipid Metabolism, and Inflammation in Menopausal Women

Influence of Milk Polar Lipids Intake on Lipid Metabolism, Body Composition, Inflammation and Intestinal Microbiota in Menopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Female
Age
75 Years
Healthy volunteers
Not accepted

Summary

Polar lipids have a specific chemical structure: they are an essential component of human cell membranes, play a major role in the nervous system and also influence the metabolic pathways including the cholesterol metabolism. Polar lipids are used in food-processing industry for their emulsification properties. The most famous emulsifier is soya lecithin but milk also naturally contains natural emulsifiers such as polar lipids. The purpose of this research is to study plasma cholesterol variation after daily intake of milk polar lipids-fortified cheese products. The volunteers will have to consume 100 g of cheese product during four weeks instead of their usual cheese products. It is a bi-centric study with a centre in LYON (Centre de Recherche en Nutrition Humaine Rhône-Alpes) and CLERMONT-FERRAND (Centre de Recherche en Nutrition Humaine Auvergne).

Conditions

Interventions

TypeNameDescription
OTHER3g milk polar lipid fortified cheese consumptionWomen will have to consume daily 100g of a 3g milk polar lipid fortified cheese product instead of usual cheese products during four weeks.
OTHER5g milk polar lipid fortified cheese consumptionWomen will have to consume daily 100g of a 5 g milk polar lipid fortified cheese product instead of usual cheese products during four weeks.
OTHERUnfortified cheese product consumptionWomen will have to consume daily 100g of a unfortified cheese product instead of usual cheese products during four weeks

Timeline

Start date
2014-03-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-03-28
Last updated
2021-01-27

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02099032. Inclusion in this directory is not an endorsement.